System1 Biosciences

System1 Biosciences is a neurotherapeutics company based in San Francisco that uses phenotypic screening to discover new drugs for complex neurological and psychiatric disorders such as epilepsy, autism, and schizophrenia. System1 combines brain organoid science, systems neuroscience, robotic automation, and advanced data analytics to uncover unprecedented disease signatures, which are then used to identify new therapeutic targets and drug treatments.